1. Home
  2. TKR vs AXSM Comparison

TKR vs AXSM Comparison

Compare TKR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKR
  • AXSM
  • Stock Information
  • Founded
  • TKR 1899
  • AXSM 2012
  • Country
  • TKR United States
  • AXSM United States
  • Employees
  • TKR N/A
  • AXSM N/A
  • Industry
  • TKR Metal Fabrications
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TKR Industrials
  • AXSM Health Care
  • Exchange
  • TKR Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • TKR 5.1B
  • AXSM 5.1B
  • IPO Year
  • TKR N/A
  • AXSM 2015
  • Fundamental
  • Price
  • TKR $77.55
  • AXSM $118.42
  • Analyst Decision
  • TKR Buy
  • AXSM Strong Buy
  • Analyst Count
  • TKR 10
  • AXSM 17
  • Target Price
  • TKR $79.56
  • AXSM $175.76
  • AVG Volume (30 Days)
  • TKR 667.8K
  • AXSM 597.5K
  • Earning Date
  • TKR 11-04-2025
  • AXSM 11-11-2025
  • Dividend Yield
  • TKR 1.81%
  • AXSM N/A
  • EPS Growth
  • TKR N/A
  • AXSM N/A
  • EPS
  • TKR 4.40
  • AXSM N/A
  • Revenue
  • TKR $4,514,100,000.00
  • AXSM $495,033,000.00
  • Revenue This Year
  • TKR N/A
  • AXSM $64.05
  • Revenue Next Year
  • TKR $3.14
  • AXSM $56.46
  • P/E Ratio
  • TKR $17.62
  • AXSM N/A
  • Revenue Growth
  • TKR N/A
  • AXSM 69.83
  • 52 Week Low
  • TKR $56.20
  • AXSM $75.56
  • 52 Week High
  • TKR $87.52
  • AXSM $139.13
  • Technical
  • Relative Strength Index (RSI)
  • TKR 51.43
  • AXSM 50.90
  • Support Level
  • TKR $75.50
  • AXSM $123.54
  • Resistance Level
  • TKR $79.07
  • AXSM $130.00
  • Average True Range (ATR)
  • TKR 1.61
  • AXSM 3.75
  • MACD
  • TKR 0.01
  • AXSM -0.49
  • Stochastic Oscillator
  • TKR 56.00
  • AXSM 17.34

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: